CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/II Study of BMS-247550 and Pegylated Liposomal Doxorubicin (Doxil®) in Patients With Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer Who Have Been Previously Treated With a Platinum and a Taxane

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00182767
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:58.985008+00:00
Published At: 2016-03-10T00:00:00+00:00
Record Updated At: 2016-03-10
Results Posted At: 2016-03-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Fallopian Tube Cancer", "Female Reproductive Cancer", "Recurrent Breast Cancer", "Recurrent Ovarian Epithelial Cancer", "Stage III Ovarian Epithelial Cancer", "Stage IV Breast Cancer", "Stage IV Ovarian Epithelial Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-03-10"
protocolSection.identificationModule.nctId: "NCT00182767"
protocolSection.identificationModule.officialTitle: "A Phase I/II Study of BMS-247550 and Pegylated Liposomal Doxorubicin (Doxil\u00ae) in Patients With Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer Who Have Been Previously Treated With a Platinum and a Taxane"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-03-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.